Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger's disease)

被引:27
|
作者
Hooten, WM
Bruns, HK
Hays, JT
机构
[1] Mayo Clin & Mayo Fdn, Div Gen Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Nicotine Dependence Ctr, Rochester, MN 55905 USA
关键词
D O I
10.4065/73.6.529
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thromboangiitis obliterans (TAO), or Buerger's disease, is an inflammatory, occlusive, and nonatherosclerotic vascular disease that most commonly affects small and medium-sized arteries and veins. The association between tobacco use and the development of TAO is incontestable; however, a substantial number of patients with TAO continue to use tobacco despite progression of disease and amputation. Herein we describe a patient with advanced TAO whose severe, refractory nicotine dependence was successfully treated in a specialized nicotine-dependence inpatient program. After cessation of smoking, the patient's disease stabilized, Inpatient nicotine-dependence treatment may represent an alternative for recidivist smokers with severe tobacco-related disease.
引用
下载
收藏
页码:529 / 532
页数:4
相关论文
共 50 条
  • [41] Buerger Disease (Thromboangiitis Obliterans): A Clinical Diagnosis
    Highlander, Peter
    Southerland, Charles C.
    VonHerbulis, Eric
    Gonzalez, Aldo
    ADVANCES IN SKIN & WOUND CARE, 2011, 24 (01) : 15 - 17
  • [42] A prospective case-control study of tobacco dependence in Thromboangiitis obliterans (Buerger's disease)
    Cooper, LT
    Henderson, SS
    Offord, KP
    Tse, TS
    Holmes, DR
    Hurt, RD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 304A - 305A
  • [43] A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's disease)
    Cooper, LT
    Henderson, SS
    Ballman, KV
    Offord, KP
    Tse, TS
    Holmes, DR
    Hurt, RD
    ANGIOLOGY, 2006, 57 (01) : 73 - 78
  • [44] Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue
    Kosmas I. Paraskevas
    Clinical Rheumatology, 2008, 27 : 547 - 547
  • [45] Successful treatment of thromboangiitis obliterans (Buerger’s disease) with immunoadsorption: results of a pilot study
    Gert Baumann
    Verena Stangl
    Peter Klein-Weigel
    Karl Stangl
    Michael Laule
    Kathrin Enke-Melzer
    Clinical Research in Cardiology, 2011, 100 : 683 - 690
  • [46] Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study
    Baumann, Gert
    Stangl, Verena
    Klein-Weigel, Peter
    Stangl, Karl
    Laule, Michael
    Enke-Melzer, Kathrin
    CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (08) : 683 - 690
  • [47] Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue
    Paraskevas, Kosmas I.
    CLINICAL RHEUMATOLOGY, 2008, 27 (04) : 547 - 547
  • [48] A Case of Recurrent Thromboangiitis Obliterans (Buerger's Disease) in a Patient With Abdominal Pain and Intestinal Transplant
    Kaiser, Arsh
    Jafri, Syed-Mohammed
    Varma, Adarsh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2208 - S2209
  • [49] Thromboangiitis Obliterans (Buerger's disease) : An Observational Study of 174 Patients
    Le Joncour, Alexandre
    Soudet, Simon
    Maillard, Helene
    Koskas, Fabien
    Cluzel, Philippe
    Hachulla, Eric
    Hatron, Pierre-Yves
    Cacoub, Patrice
    Lambert, Marc
    Saadoun, David
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans)
    Beigi, Ali Akbar
    Hoghoughi, Mohammad Ali
    Eshaghian, Afrooz
    Zade, Akbar Hassan
    Masoudpour, Hassan
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (11): : 1034 - 1037